Strata Skin Sciences
(OTC) SSKN
Strata Skin Sciences Financials at a Glance
Market Cap
$2.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$30.70M
Net Income (TTM)
-$6.49M
EPS (TTM)
-$1.53
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-4822.28 (Low)
Dividend
$0.00
Beta (Volatility)
-4822.28 (Low)
Price
$0.00
Volume
16,144
Open
$0.00
Price
$0.00
Volume
16,144
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $3.86
Estimated Earnings Date
May 26, 2026
Dividend
$0.00
Beta (Volatility)
-4822.28 (Low)
Price
$0.00
Volume
16,144
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $3.86
Estimated Earnings Date
May 26, 2026
SSKN News
3 Stocks Shaking the Market
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Strata Skin Sciences
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
114
CEO
Dolev Rafaeli, PhD, MBA
Website
www.strataskinsciences.comHeadquarters
Horsham, PA 19044, US
SSKN Financials
Key Financial Metrics (TTM)
Gross Margin
57.83%
Operating Margin
-19.74%
Net Income Margin
-21.13%
Return on Equity
-360.33%
Return on Capital
-30.43%
Return on Assets
-21.25%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
5.89M
Volume
16.14K
Avg. Volume
12.92K
Financials (TTM)
Gross Profit
$17.75M
Operating Income
-$6.06M
EBITDA
-$564.00K
Operating Cash Flow
-$2.79M
Capital Expenditure
-$1.47M
Free Cash Flow
-$4.26M
Cash & ST Invst.
$7.91M
Total Debt
$16.27M
Strata Skin Sciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$9.29M
-3.0%
Gross Profit
$5.61M
-2.5%
Gross Margin
60.42%
N/A
Market Cap
$2.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$22.64
N/A
Employees
106
N/A
Net Income
$58.00K
+101.3%
EBITDA
$943.00K
+133.2%
Quarterly Fundamentals
Total Cash
$7.91M
+9.0%
Total Debt
$16.27M
-1.0%
Accounts Receivable
$4.12M
-21.5%
Inventory
$2.81M
+25.3%
Long Term Debt
$1.38M
-91.5%
Short Term Debt
$15.58M
+4650.0%
Return on Assets
-21.25%
N/A
Return on Invested Capital
-1.60%
N/A
Free Cash Flow
-$551.00K
-376.9%
Operating Cash Flow
-$239.00K
-134.0%